About Sequenom Center for Molecular MedicineSequenom Center for Molecular Medicine (Sequenom CMM®) is a CAP accredited and CLIA-certified molecular diagnostics reference laboratory currently with three locations dedicated to the development and commercialization of laboratory-developed tests for prenatal and eye conditions and diseases. Utilizing innovative proprietary technologies, Sequenom CMM provides test results that can be used by health care professionals in managing patient care. Testing services are available only upon request by physicians. Sequenom CMM works closely with key opinion leaders and experts in obstetrics, retinal care and genetics. Sequenom CMM scientists use a variety of sophisticated and cutting-edge methodologies in the development and validation of tests. Sequenom CMM is changing the landscape in genetic diagnostics. Visit http://www.sequenomcmm.com for more information on laboratory testing services.
SEQUENOM®, and MaterniT21™ PLUS are trademarks of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.
Forward-Looking Statements Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the Company's expectations regarding improvements in reimbursement and collections of diagnostic segment revenues during the second half of 2013 and the magnitude and timing of such improvements, opportunities for renewed efficiencies with regard to the Company's spending plans for the second half of 2013 and the Company's plan to implement expense reduction initiatives to reduce net operating loss, the annualized run rate for the MaterniT21 PLUS test at the end of the second qu
|SOURCE Sequenom, Inc.|
Copyright©2012 PR Newswire.
All rights reserved